Hospital readmissions after robotic hepatectomy for neoplastic disease: Analysis of risk factors, survival, and economical impact. A logistical regression and propensity score matched study.
Am J Surg
; 234: 92-98, 2024 Aug.
Article
en En
| MEDLINE
| ID: mdl-38519401
ABSTRACT
BACKGROUND:
As the first comprehensive investigation into hospital readmissions following robotic hepatectomy for neoplastic disease, this study aims to fill a critical knowledge gap by evaluating risk factors associated with readmission and their impact on survival and the financial burden.METHODS:
The study analyzed a database of robotic hepatectomy patients, comparing readmitted and non-readmitted individuals post-operatively using 11 propensity score matching. Statistical methods included Chi-square, Mann-Whitney U, T-test, binomial logistic regression, and Kaplan-Meier analysis.RESULTS:
Among 244 patients, 44 were readmitted within 90 days. Risk factors included hypertension (p â= â0.01), increased Child-Pugh score (p â< â0.01), and R1 margin status (p â= â0.05). Neoadjuvant chemotherapy correlated with lower readmission risk (p â= â0.045). Readmissions didn't significantly impact five-year survival (p â= â0.42) but increased fixed indirect hospital costs (p â< â0.01).CONCLUSIONS:
Readmission post-robotic hepatectomy correlates with hypertension, higher Child-Pugh scores, and R1 margins. The use of neoadjuvant chemotherapy was associated with a lower admission rate due to less diffuse liver disease in these patients. While not affecting survival, readmissions elevate healthcare costs.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Readmisión del Paciente
/
Puntaje de Propensión
/
Procedimientos Quirúrgicos Robotizados
/
Hepatectomía
/
Neoplasias Hepáticas
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Am J Surg
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Estados Unidos